5-HT Receptor Agonist

E-55888 is a selective and potent agonist of 5-HT₇ receptor and 5-HT_1A receptor with K_i values of 2.5 nM and 700 nM, respectively, which has analgesic and antinociceptive effects. E-55888 reduces the nociceptive response of Capsaicin (HY-10448) sensitized mice.

5-HT7 agonist 1 is a selective 5-HT7 receptor agonist, with an IC₅₀ of 222.93 nM, can be used for the 5-HT7 receptor related disease, such as CNS disorders.

TAAR1/5-H-2CR agonist-1 (compound 21b) is a TAAR1 and 5-HT_2CR dual agonist with EC₅₀s of 0.022 and 0.246 μM, respectively. TAAR1/5-H-2CR agonist-1 can used in the study of schizophrenia and Alzheimer's Disease.

IHCH-8110 is a peripherally restricted, non-brain-penetrant 5-HT_2AR and 5-HT_2CR agonist (K_i=47.86 nM) that antagonizes 5-HT_2BR. IHCH-8110 induces CXCL10 and IL-18 expression by activating 5-HT_2AR on enteric glial cells, thereby promoting CD8⁺ T cell recruitment and effector polarization, and avoids the risk of cardiac valvulopathy associated with 5-HT_2BR activation. IHCH-8110 exhibits a low risk of hERG channel inhibition (IC₅₀=5.96 μM) and is well tolerated, sensitizing immunologically cold colorectal cancer to PD-1 blockade therapy, making it suitable for research related to colorectal cancer.

5-HT2A agonist-11 (Compound S82) is a 5-HT2A receptor agonist with an EC₅₀ of 1.5 nM. 5-HT2A agonist-11 can be used for the research of central nervous system diseases.

5-HT2C agonist-5 (Compound 3A) is a 5-HT2C agonist (EC₅₀: <1 nM). 5-HT2C agonist-5 can be used for research of brain disorders.

PF-4479745 is a potent and selective 5-HT_2C receptor agonist (EC₅₀: 10 nM, k_i: 15 nM). PF-4479745 can be used in the research of cardiovascular disease like hypertension.

5-HT2A agonist 3 (Compound P-141) is a selective 5-hydroxytryptamine 2A receptor (5-HT_2A) agonist with an EC₅₀ value of 13.80 nM. 5-HT2A agonist 3 is promising for research of mental illnesses such as depression, post-traumatic stress disorder, obsessive-compulsive disorder, and central nervous system disorders.

AL-34662 (formate) is a 5-HT₂ receptor agonist (IC₅₀: 0.8-1.5 nM). AL-34662 (formate) stimulates inositol phosphate turnover and Ca²⁺ release in human ciliary muscle cells (h-CM) (E₅₀: 289 nM) and human trabecular meshwork cells (h-TM) (E₅₀: 254 nM). AL-34662 (formate) can be used in studies to lower intraocular pressure (IOP).

5-HT4R agonist-2 (Compound 4) is a selective 5-HT4R agonist with an EC₅₀ value of 0.41 nM. 5-HT4R agonist-2 can significantly enhance whole gut and colonic transit, increase fecal output and water content, while maintaining minimal systemic absorption, and it shows promise for the research of chronic idiopathic constipation.

Sumatriptan (succinate) (Standard) is the analytical standard of Sumatriptan (succinate). This product is intended for research and analytical applications. Sumatriptan succinate (GR 43175) is an orally active 5-HT1 receptor agonist with K_is of 17 nM, 27 nM and 100 nM for 5-HT1D, 5-HT1B and 5-HT1A receptors, respectively. Sumatriptan succinate can be used for migraine headache research.

RS 67333 is a 5-HT4R agonist with stress-preventive activity. RS 67333 attenuates stress-induced body weight changes and prevents depression- and anxiety-like behaviors in two mouse strains tested in different stress models.

Almotriptan malate (Standard) is the analytical standard of Almotriptan malate (HY-B0383). This product is intended for research and analytical applications. Almotriptan malate (PNU180638) is an orally active, highly selective agonist of the 5-HT_1B/1D receptor (5-HT_1B/1D receptor), with EC₅₀ values of 1.6 nM and 3.1 nM, respectively. Almotriptan malate shows moderate affinity for the 5-HT1F receptor, and weak affinity for the 5-HT1A, 5-HT6 and 5-HT7 receptors. Almotriptan malate induces intracranial vasoconstriction, inhibits nociceptive neurotransmission in the trigeminocervical complex, and suppresses the release of vasoactive peptides from trigeminal nerve endings. Almotriptan malate can be used in research related to migraine.

Sumatriptan-d₆ (formate) (GR 43175 free base-d₆ (formate)) is deuterium labeled Sumatriptan. Sumatriptan (GR 43175) is an orally active 5-HT1 receptor agonist with IC₅₀s of 7.3 nm, 9.3nm and 17.8 nm for 5-HT_1D, 5-HT_1B and 5-HT_1F receptors, respectively. Sumatriptan can be used for migraine headache research.

2,4-DMA hydrochloride is a serotonin 5-HT2 receptor agonist with an apparent PA₂ value of 5.6.

5-HT2A agonist 5 (Compound 88) is a 5-HT2A agonist with an EC₅₀ of 0.01  nM for h5-HT2A. 5-HT2A agonist 5 can be used for depression, drug addiction, alcoholism, post-traumatic stress disorder (PTSD), and neuropathic pain research.

TKS 159 is a 5-HT4 receptor agonist. TKS 159 can promote gastrointestinal motility. TKS 159 can be used for research on gastrointestinal conditions.

3,4-Dihydro Naratriptan is a serotonin 5-HT1-receptor agonist. 3,4-Dihydro Naratriptan exhibits selective vasoconstrictor activity. 3,4-Dihydro Naratriptan can be used for migraine diseases research.

Naratriptan (GR-85548A) hydrochloride (Standard) is the analytical standard of Naratriptan hydrochloride (HY-B0197A). This product is intended for research and analytical applications. Naratriptan is a selective 5-HT1B/1D receptor agonist. Naratriptan is peripherally active and has good oral bioavailability, inducing cranial artery vasoconstriction by activating 5-HT1B/1D receptors (EC₅₀=0.11 μM for dog basilar artery). Naratriptan also inhibits trigeminal nerve-mediated dural neurogenic plasma extravasation and reduces sterile inflammation. Naratriptan is mainly used in the research of acute migraine, targeting cranial vascular and neuroinflammatory mechanisms.

LY 344864 hydrochloride is a selective, orally active 5-HT_1F receptor agonist with a K_i of 6 nM. LY 344864 hydrochloride is a full agonist producing an effect similar in magnitude to serotonin itself. LY 344864 hydrochloride can cross the blood brain barrier to some extent.